SYNGEN BIOTECH CO LTD financial statements, including revenue, expenses, profit, and loss

The total revenue of 8279 for the last quarter is 555.55 M TWD, and it's 7.73% higher compared to the previous quarter. The net income of Q3 24 is 72.30 M TWD.